Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Coppola

Showing results (231-240 of 241) with videos related to

Pageof 25
Sort By:
Journal of Medicinal Chemistry|October 14, 2005
Perhydroquinolylbenzamides as novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1Gary M Coppola, Paivi J Kukkola, James L Stanton, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2005
Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomasGuoan Chen, Mahaveer S Bhojani, Andrew C Heaford, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial TriglyceridesMichael H Serrano-Wu, Gary M Coppola, Yongjin Gong, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Brain neuromarkers predict self- and other-related mentalizing across adult, clinical, and developmental samplesDorukhan Açıl, Jessica R Andrews-Hanna, Marina Lopez-Sola, et al.
Nature Communications|June 6, 2026
Brain neuromarkers predict self- and other-related mentalizing across adult, clinical, and developmental samplesDorukhan Açıl, Jessica R Andrews-Hanna, Marina López-Solà, et al.
Journal of Medicinal Chemistry|May 13, 2017
Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in HumansKatsumasa Nakajima, Ricardo Chatelain, Kevin B Clairmont, et al.
Journal of Medicinal Chemistry|January 29, 2000
Secondary amides of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinaseT D Aicher, R C Anderson, J Gao, et al.
Minerva Urology and Nephrology|February 16, 2026
Accuracy, readability, and understandability of EAU Guidelines Bot for urinary infections guidelinesManfredi B Sequi, Riccardo Lombardo, Ludovica M Coppola, et al.
Journal of Medicinal Chemistry|July 30, 1999
(R)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionamides are orally active inhibitors of pyruvate dehydrogenase kinaseT D Aicher, R C Anderson, G R Bebernitz, et al.
ACS Medicinal Chemistry Letters|February 20, 2020
Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin InhibitorsToshio Kawanami, Rajeshri G Karki, Emma Cody, et al.
Pageof 25

Showing results (231-240 of 241) with videos related to

Sort By:
Pageof 25
Journal of Medicinal Chemistry|October 14, 2005
Perhydroquinolylbenzamides as novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1Gary M Coppola, Paivi J Kukkola, James L Stanton, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2005
Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomasGuoan Chen, Mahaveer S Bhojani, Andrew C Heaford, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial TriglyceridesMichael H Serrano-Wu, Gary M Coppola, Yongjin Gong, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Brain neuromarkers predict self- and other-related mentalizing across adult, clinical, and developmental samplesDorukhan Açıl, Jessica R Andrews-Hanna, Marina Lopez-Sola, et al.
Nature Communications|June 6, 2026
Brain neuromarkers predict self- and other-related mentalizing across adult, clinical, and developmental samplesDorukhan Açıl, Jessica R Andrews-Hanna, Marina López-Solà, et al.
Journal of Medicinal Chemistry|May 13, 2017
Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in HumansKatsumasa Nakajima, Ricardo Chatelain, Kevin B Clairmont, et al.
Journal of Medicinal Chemistry|January 29, 2000
Secondary amides of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinaseT D Aicher, R C Anderson, J Gao, et al.
Minerva Urology and Nephrology|February 16, 2026
Accuracy, readability, and understandability of EAU Guidelines Bot for urinary infections guidelinesManfredi B Sequi, Riccardo Lombardo, Ludovica M Coppola, et al.
Journal of Medicinal Chemistry|July 30, 1999
(R)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionamides are orally active inhibitors of pyruvate dehydrogenase kinaseT D Aicher, R C Anderson, G R Bebernitz, et al.
ACS Medicinal Chemistry Letters|February 20, 2020
Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin InhibitorsToshio Kawanami, Rajeshri G Karki, Emma Cody, et al.
Pageof 25